Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 88 entries
Sorted by: Best Match Show Resources per page
Pulmonary hypertension.

Current opinion in pulmonary medicine

Humbert M, Channick RN.
PMID: 27428648
Curr Opin Pulm Med. 2016 Sep;22(5):399. doi: 10.1097/MCP.0000000000000309.

No abstract available.

Bibliography. Current world literature: neoplasms of the lung.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 11478288
Curr Opin Pulm Med. 2001 Jul;7(4):B63-76.

No abstract available.

Bibliography. Current world literature. Cystic fibrosis.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 10570744
Curr Opin Pulm Med. 1999 Nov;5(6):B126-31.

No abstract available.

Bibliography. Current world literature. Cystic fibrosis.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 15599968
Curr Opin Pulm Med. 2004 Nov;10(6):561-7.

No abstract available.

Bibliography. Current world literature. Cystic fibrosis.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 18816887
Curr Opin Pulm Med. 2008 Nov;14(6):602-3.

No abstract available.

Current world literature.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 23361198
Curr Opin Pulm Med. 2013 Mar;19(2):181-7. doi: 10.1097/MCP.0b013e32835e1cd9.

No abstract available.

ABPA Concomitantly Occurring with Invasive Sinus Aspergillosis: A Short Report on Two Patients.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Mohindra S, Mehta R, Bal A.
PMID: 24533410
Indian J Otolaryngol Head Neck Surg. 2014 Jan;66:329-33. doi: 10.1007/s12070-011-0301-z. Epub 2011 Sep 04.

Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder that is caused by hypersensitivity to Aspergillus fumigatus with resultant systemic immune activation, chronic asthma, recurrent pulmonary infiltrates, and bronchiectasis. First described by Hinson et al. (Thorax 7:317-333 [1]) in 1952,...

Chronic obstructive pulmonary disease (COPD).

Current opinion in pulmonary medicine

Varkey B.
PMID: 21252679
Curr Opin Pulm Med. 2011 Mar;17(2):55. doi: 10.1097/MCP.0b013e328343c263.

No abstract available.

Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security.

Current opinion in pulmonary medicine

Zumla A, Niederman MS.
PMID: 32132379
Curr Opin Pulm Med. 2020 May;26(3):193-196. doi: 10.1097/MCP.0000000000000676.

No abstract available.

Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic.

Current opinion in pulmonary medicine

Sculley JA, Musick H, Krishnan JA.
PMID: 34860202
Curr Opin Pulm Med. 2021 Dec 01; doi: 10.1097/MCP.0000000000000851. Epub 2021 Dec 01.

PURPOSE OF REVIEW: Many healthcare systems rapidly implemented telehealth as a substitute for in-person care during the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this review is to describe the evidence base supporting the use of telehealth for...

The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.

Current opinion in pulmonary medicine

Tiew PY, Mac Aogáin M, Chotirmall SH.
PMID: 34839338
Curr Opin Pulm Med. 2021 Nov 24; doi: 10.1097/MCP.0000000000000850. Epub 2021 Nov 24.

PURPOSE OF REVIEW: Next-generation sequencing (NGS) has deepened our understanding of the respiratory microbiome in health and disease. The number of microbiome studies employing sputum as an airway surrogate has continued to increase over the past decade to include...

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?.

Current opinion in pulmonary medicine

Wang JM, Han MK, Labaki WW.
PMID: 34652295
Curr Opin Pulm Med. 2021 Oct 13; doi: 10.1097/MCP.0000000000000833. Epub 2021 Oct 13.

PURPOSE OF REVIEW: Risk assessment tools are essential in COPD care to help clinicians identify patients at higher risk of accelerated lung function decline, respiratory exacerbations, hospitalizations, and death.RECENT FINDINGS: Conventional methods of assessing risk have focused on spirometry,...

Showing 1 to 12 of 88 entries